Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone

A. E. Takemori, M. Sultana, H. Nagase, P. S. Portoghese

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Abstract

The pharmacological profile of naltrindole (NTI) and three of its analogues, N-methyl-NTI (N-Me-NTI), oxymorphindole (OMI) and naltriben (NTB) were studied in antinociceptive assays. The compounds were found to have agonist activities that appear to be mediated mainly by κ opioid receptors because norbinaltorphimine (nor-BNI), the selective κ opioid receptor antagonist inhibited their effects significantly. All of the compounds, behaved as antagonists at doses that were lower than those that produced agonist effects and they possessed a profilethat was very selective for inhibiting the antinociceptive activities of δ opioid receptor agonists. Differential antagonism by NTB of the activities of DSLET and DPDPE was demonstrated.

Original languageEnglish (US)
Pages (from-to)1491-1495
Number of pages5
JournalLife Sciences
Volume50
Issue number20
DOIs
StatePublished - 1992

Bibliographical note

Funding Information:
This investigation was supported by U. S. Public Service Grants from the National Institute on Drug Abuse. We thank the technical assistance of Mary Lunzer.

Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.

Fingerprint

Dive into the research topics of 'Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone'. Together they form a unique fingerprint.

Cite this